Stroke prevention in elderly atrial fibrillation patients remains a challenge. There is a high risk of stroke and systemic thromboembolism but also a high risk of bleeding if anticoagulants are prescribed. The elderly have increased chronic kidney disease, coronary artery disease, polypharmacy, and overall frailty. For all these reasons, anticoagulant use is underutilized in the elderly. In this manuscript, the benefits of non-vitamin K antagonist oral anticoagulants compared with warfarin in the elderly patient population with multiple comorbid conditions are reviewed.
CITATION STYLE
Turagam, M. K., Velagapudi, P., & Flaker, G. C. (2015, September 3). Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: Focus on non-vitamin K antagonist oral anticoagulants. Clinical Interventions in Aging. Dove Medical Press Ltd. https://doi.org/10.2147/CIA.S80641
Mendeley helps you to discover research relevant for your work.